Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc.) on December 27, 2012. The report addresses the announcement of consolidated financial results for the second quarter of fiscal year 2013 and, more critically, a material restatement of the first quarter ended August 26, 2012.
Key Financial Metrics and Material Changes
The filing details a significant accounting error regarding the valuation of an investment in Windset Holdings 2010, Ltd. ("Windset").
- Investment Valuation Error: An error in the net present value calculation under ASC 820 led to an understatement of the Windset investment value by $2.9 million.
- Net Income Impact: The error resulted in an understatement of net income by $1.8 million (after tax) for the quarter ended August 26, 2012.
- Revenue and Cash Flow: The filing explicitly states there is no effect on revenues, operating income, or cash flows from operating, investing, or financing activities.
- Restatement Action: The Company will restate the previously issued Form 10-Q for the quarter ended August 26, 2012, to reflect the corrected investment balance and increased other income.
Guidance, Risks, and Internal Controls
Management and the audit committee have reassessed internal controls following the discovery of the error.
- Material Weakness: The Company concluded there was a material weakness in its internal control over financial reporting as of August 26, 2012.
- Remediation: Plans for remediation will be detailed in the amended Form 10-Q.
- Non-Reliance: Investors are advised not to rely on the previously issued financial statements for the quarter ended August 26, 2012.
- Outlook: The filing does not provide specific forward-looking guidance or updated financial projections beyond the restatement details.
- Verify the corrected financial figures in the upcoming amended Form 10-Q for the quarter ended August 26, 2012.
- Review the specific details of the material weakness in internal controls and the remediation plan in the amended filing.
- Confirm that the $2.9 million adjustment applies solely to the fair value of the Windset investment and does not impact operational cash flows.
- Note that the filing text does not provide specific revenue, profit, or liquidity figures for the current quarter (Q2 FY2013) beyond the reference to the press release (Exhibit 99.1).